Swelling or redness at the injection site may also occur
Stability of GLP-1 analogs To evaluate the stability of GLP-1 and its analogs against DPP-IV activity, peptides were incubated at an initial concentration of 100 nM in DMEM containing 10% FBS or in 100% FBS at 37 for 0, 12, 24, 48, 72, and 96 hours in the presence or absence of 0.2 mM DPP-IV inhibitor diprotin A (Sigma-Aldrich, St Louis, MO, USA)
Because MASH is a significant risk factor for cardiovascular disease and events, this remains an important area for future investigation [154]
You cannot predict your individual response from population averages
Subsequently, we discuss resistance patterns across different treatment modalities, including chemotherapy, targeted therapy, immunotherapy and hormonal therapy, and highlight emerging technologies and translational strategies to overcome resistance